Very low calorie diet without aspartame in obese subjects: improved metabolic control after 4 weeks treatment

Nutrition Journal

Henrik Forssell²  Erik Norén¹ 

[1] Department of General Surgery, Blekinge County Hospital, Lasarettsvägen, 371 85 Karlskrona, Sweden;Blekinge Centre of Competence, Vårdskolevägen, 37181 Karlskrona, Sweden

关键词: Weight reduction;    Artificial sweetener;    Aspartame;    Fructose;    VLCD;    Obesity;   

Others  :  1132523
DOI  :  10.1186/1475-2891-13-77

 received in 2014-02-18, accepted in 2014-07-16,  发布年份 2014

【 摘 要 】

Background

Very low calorie diet (VLCD) is routinely used in programs for treatment of obesity and before bariatric surgery in order to reduce risk of postoperative complications. Aspartame, an artificial sweetener, is commonly used in VLCD and is well approved as a food additive without any adverse effects. The development of a new fructose containing VLCD formula without aspartame raises questions as to effects on glucose and lipid control.

Methods

As part of an ongoing study of a novel bariatric surgery procedure, twenty-five obese subjects with mean body mass index (BMI) 39.8 kg/m² and mean age of 48.8 years enrolled in a single center observational study. Seven subjects presented with type 2 diabetes mellitus. The subjects underwent four weeks dietary treatment with VLCD Slanka (Slanka®). Blood samples including fasting plasma glucose, HbA1c, cholesterol and triglycerides were performed at start and after four weeks of diet. Blood pressure and weight were noted.

Results

All subjects completed the diet without any adverse events. Mean weight reduction was 8.2 kg with 95% confidence interval 7.1–9.2 kg (p = 0.001). Excess weight (i.e. proportion of weight exceeding BMI 25) loss decreased by median 19.5% (inter quartile range (IQR) 16,8-24,2). Median fasting plasma glucose was at inclusion 5,6 mmol/l (IQR 5,3-6,8) and after diet 4.8 mmol/l (IQR 4,6-5,2) (p = 0.001). Median HbA1c changed from 39 mmol/mol (IQR 37–44) to 37 mmol/mol (IQR 35–43) (p = 0.001). There was also significant reduction in cholesterol and triglyceride levels as well as in systolic blood pressure. Changes in other monitored blood chemistry values were without clinical importance.

Conclusion

Four weeks treatment with fructose containing VLCD of obese subjects preparing for bariatric surgery gave a substantial weight reduction without any significant negative metabolic effects.

【 授权许可】

   
2014 Norén and Forssell; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Flegal K, Carroll MD, Kit BK, Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012, 307:491-497.
• [2]Freedman DM, Ron E, Ballard-Barbash R, Doody MM, Linet MS: Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) 2006, 30:822-829.
• [3]Sjöström L, Narbo K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752.
• [4]Marsk R, Näslund E, Freedman J, Tynelius P, Rasmussen F: Bariatric surgery reduces mortality in Swedish men. Br J Surg 2010, 97:877-883.
• [5]Colles SL, Dixon JB, Marks P, Strauss BJ, O'Brien PE: Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr 2006, 84:304-311.
• [6]Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A, van Dielen F, Wiezer R, Janssen I, Kramer M, Thorell A: Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg 2011, 146:1300-1305.
• [7]Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Getha RS, Herelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Schaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK: Aspartame: review of safety. Regul Toxicol Pharmacol 2002, 35:1-93.
• [8]Curtius HC, Endres W, Blau N: Effect of high-protein meal plus aspartame ingestion on plasma phenylalanin concentrations in obligate heterozygotes for phenylketonuria. Metabolism 1994, 43:413-416.
• [9]SW R: Health implications of fructose consumption: A review of recent data. Nutr Metab (Lond) 2010, 7:82.
• [10]Ahn Y, Park SJ, Kwack HK, Kim MK, Ko KP, Kim SS: Rice-eating pattern and the risk of metabolic syndrome especially waist circumference in Korean Genome and Epidemiology Study (KoGES). BMC Public Health 2013, 13:61.
• [11]Chiu S, Sievenpiper JL, de Souza RJ, Cozma A, Mirrahimi A, Carleton AJ, Ha V, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Don-Wauchope AC, Beyene J, Kendall CW, Jenkins DJ: Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 2014, 68:416-423.
• [12]Wikstrand I, Torgerson J, Boström KB: Very low calorie diet (VLCD) followed by a randomized trial of corset treatment for obesity in primary care. Scand J Prim Health Care 2010, 28:89-94.
• [13]Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM: Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002, 4:407-414.
• [14]Gu Y, Yu H, Li Y, Ma X, Lu J, Yu W, Xiao Y, Bao Y, Jia W: Beneficial effects of an 8-week, very low carbohydrate diet intervention on obese subjects. Evid Based Complement Alternat Med 2013, 2013:760804.
• [15]Jackness C, Karmally W, Febres G, Conwell IM, Ahmed L, Bessler M, McMahon DJ, Korner J: Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell function in type 2 diabetic patients. Diabetes 2013, 62:3027-3032.
• [16]Lips MA, de Groot GH, van Klinken JB, Aarts E, Berends FJ, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, van Dijk W, Pijl H: Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients. Clin Endocrinol (Oxf) 2013. epub ahead of print
• [17]Jazet IM, Pijl H, Frölich M, Schoemaker RC, Meinders AE: Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patiens. Diabet Med 2005, 22:52-55.
• [18]Jazet IM, de Craen AJ, van Schie EM, Meinders AE: Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes. Diabete Res Clin Pract 2007, 77:70-76.
• [19]Shaw KA, O'Rourke P, Del Mar C, Kenardy J: Psychological interventions for overweight or obesity. Cochrane Database Syst Rev 2005., 2CD003818
• [20]Avenell A, Brown TJ, McGee MA, Campbell MK, Grant AM, Broom J, Jung RT, Smith WC: What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet 2004, 17:317-335.